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MaOBJECTIVES This study evaluated the accuracy of T2, T1, and extracellular volume (ECV) quantiﬁcation as novel
quantitative tissue markers in comparison with standard “Lake-Louise” cardiac magnetic resonance (CMR) criteria to
diagnose myocarditis.
BACKGROUND Novel approaches using T2 and T1 mapping may overcome the limitations of signal intensity-based
parameters, which would potentially result in a better diagnostic accuracy compared with standard CMR techniques
in suspected myocarditis.
METHODS CMR was performed in 104 patients with myocarditis and 21 control subjects at 1.5-T. Patients with
myocarditis underwent CMR 2 weeks (interquartile range: 1 to 7 weeks) after presentation with new-onset heart
failure (n ¼ 66) or acute chest pain (n ¼ 38). T2 and T1 mapping were implemented into a standard protocol including
T2-weighted (T2w), early gadolinium enhancement (EGE) CMR, and late gadolinium enhancement (LGE) CMR.
T2 quantiﬁcation was performed using a free-breathing, navigator-gated multiecho sequence. T1 quantiﬁcation
was performed using the modiﬁed Look-Locker inversion recovery sequence before and after administration of
0.075 mmol/kg gadobenate dimeglumine. T2, T1, and ECV maps were generated using a plug-in for the OsiriX
software (Pixmeo, Bernex, Switzerland) to calculate mean global myocardial T2, T1, and ECV values.
RESULTS The diagnostic accuracies of conventional CMR were 70% (95% conﬁdence interval [CI]: 61% to 77%)
for T2w CMR, 59% (95% CI: 56% to 73%) for EGE, and 67% (95% CI: 59% to 75%) for LGE. The diagnostic accuracies
of mapping techniques were 63% (95% CI: 53% to 73%) for myocardial T2, 69% (95% CI: 60% to 76%) for native
myocardial T1, and 76% (95% CI: 68% to 82%) for global myocardial ECV. The diagnostic accuracy of CMR was
signiﬁcantly improved to 90% (95% CI: 84% to 95%) by a stepwise approach, using the presence of LGE and
myocardial ECV $27% as diagnostic criteria, compared with 79% (95% CI: 71% to 85%; p ¼ 0.0043) for the
Lake-Louise criteria.
CONCLUSIONS In patients with clinical evidence for subacute, severe myocarditis, ECV quantiﬁcation with LGE
imaging signiﬁcantly improved the diagnostic accuracy of CMR compared with standard Lake-Louise criteria.
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ABBR EV I A T I ON S
AND ACRONYMS
AUC = area under the curve
CMR = cardiac magnetic
resonance
ECV = extracellular volume
EGE = early gadolinium
enhancement
IQR = interquartile range
LGE = late gadolinium
enhancement
LV = left ventricular
MOLLI = modiﬁed Look-Locker
inversion recovery
ROC = receiver-operating
characteristic
T1w = T1 weighted
T2w = T2 weighted
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668or skeletal muscle and, thus, are limited in
detecting and quantifying diffuse myocardial
injury (4). In contrast, T2 and T1 mapping
techniques are independent from signal in-
tensity relative to reference tissue and offer
a quantitative assessment of focal, but also
diffuse, myocardial tissue alterations (5–15).SEE PAGE 676A number of small studies indicate that
T2 and T1 mapping have the potential to
improve the diagnostic accuracy of CMR
in suspected myocarditis (6,14,16,17). Tha-
vendiranathan et al. (6) demonstrated in 30 -
patients that T2 mapping CMR reliably
identiﬁes myocardial involvement in myo-
carditis. Kellman et al. (17) found focally
elevated native T1 values and increasedextracellular volume (ECV) in 7 patients with acute
myocarditis. Ugander et al. (14) reported an increased
ECV in areas with nonischemic late gadolinium
enhancement (LGE) in 2 patients with myocarditis.
Most recently, Ferreira et al. (16) showed an excellent
accuracy of global native myocardial T1 to discrimi-
nate 50 patients with acute myocarditis from control
subjects. However, there is no comprehensive com-
parison of the diagnostic accuracies between conven-
tional CMR techniques and T2 and T1 mapping in
patients with suspected myocarditis thus far. This
study evaluated the accuracy of T2, T1, and ECV
quantiﬁcation in comparison to standard Lake-
Louise CMR criteria to diagnose myocarditis.
METHODS
PATIENTS AND CONTROLS. The study population
included 125 subjects: 104 consecutive patients with
myocarditis who underwent clinically-indicated
CMR, and a control group of 21 healthy individuals.
The local ethics committee approved the study, and
all subjects gave their written informed consent.
Exclusion criteria were concomitant coronary artery
disease, severe left ventricular hypertrophy, tako-
tsubo cardiomyopathy, and hereditary dilative car-
diomyopathy as potential confounders. All patients
with myocarditis had a history of recent airway
and/or gastrointestinal infection, had dynamically-
elevated troponin T and/or N-terminal pro–B-type
natriuretic peptide levels, and presented with 2
typical clinical scenarios: 38 (37%) patients were
referred with acute chest pain in the absence of cor-
onary artery disease; and 66 (63%) patients had new-
onset heart failure with reduced left ventricular (LV)
ejection fraction in the absence of signiﬁcantcoronary artery disease. Median interval between
onset of symptoms and CMR was 2 weeks (inter-
quartile range [IQR]: 1 to 7 weeks). The major clinical
characteristics of patients and controls are presented
in Table 1.
CMR PROTOCOL AND DATA ANALYSIS. CMR was
performed on a 1.5-T scanner (Achieva, Philips
Medical Systems, Best, the Netherlands). Edema-
sensitive black-blood T2-weighted (T2w) CMR was
performed on end-diastolic LV short-axes using a fat
suppressed (short-tau inversion recovery) triple
inversion-recovery turbo spin-echo sequence. Early
gadolinium enhancement (EGE) was assessed on
end-diastolic pre-contrast and early post-contrast
T1-weighted (T1w) spin-echo images. A bolus of
0.075 mmol/kg gadobenate dimeglumine was injec-
ted at a rate of 2.5 ml/s. Phase-sensitive inversion
recovery LGE imaging was performed on end-
diastolic short-axes. Short-axis T2 mapping was
performed before administration of contrast media in
a subset of 87 subjects. T1 mapping was performed
using the modiﬁed Look-Locker inversion recovery
(MOLLI) sequence on 3 end-diastolic LV short-axes
before and 15 min after contrast media administra-
tion. CMR data analysis was performed by 2 ob-
servers with 4 (U.K.R.) and 11 (K.M.) years of
experience in CMR who were blinded to the clinical
information. Global myocardial inﬂammation and
EGE were assessed on T2w and T1w images as
previously described (3,18,19). The presence and
pattern of nonischemic LGE lesions was qualitatively
assessed by consensus agreement of the 2 observers.
Figure 1 demonstrates typical CMR ﬁndings in a
patient with myocarditis. More detailed information
on CMR acquisition parameters and data analysis are
provided in the Online Appendix.
T2 QUANTIFICATION. T2 maps were generated of the
LV myocardium from the 9 acquired echoes per short-
axis slice using another dedicated plug-in written for
the OsiriX software (Pixmeo, Bernex, Switzerland)
(Fig. 1). Contours were manually corrected and
aligned with the contours in each respective compo-
nent image.
T1 AND ECV QUANTIFICATION. Measurements were
performed by 2 observers with 4 (U.K.R.) and 11
(K.M.) years of experience in CMR. T1 maps were
generated of LV myocardium and blood pool from
the 8 acquired images/slice using a dedicated plug-in
written for the OsiriX software (Pixmeo) (20). Native
and post-contrast T1 values were measured in the
myocardium and blood pool (Fig. 1). Global myocar-
dial ECV was measured on ECV maps, which were
generated using the previously-established equation
TABLE 1 Clinical Characteristics in Myocarditis and
Control Subjects
Myocarditis
(n ¼ 104)
Control Subjects
(n ¼ 21) p Value
Age, yrs 44 (33–58) 34 (28–47) 0.0824
Male 79 (76) 17 (81) 0.7802
BMI, kg/m2 25 (22–30) 25 (22–30) 0.4934
Creatinine, mg/dl 0.90 (0.80–1.10) 0.90 (0.73–1.00) 0.1153
Troponin T, pg/ml 43 (13–356) 5 (3–9) <0.0001
Creatine kinase, U/l 133 (76–263) 96 (113–181) 0.8287
NT-proBNP, pg/ml 2,041 (658–4,739) 28 (18–56) <0.0001
Heart rate,
beats/min
71 (60–84) 65 (61–72) 0.1040
LVEDVi, ml/m2 101 (79–148) 80 (62–88) 0.0004
LVESVi, ml/m2 60 (37–112) 28 (26–38) <0.0001
LVEF, % 42 (28–57) 59 (55–66) <0.0001
Values are median (interquartile range) or n (%).
BMI ¼ body mass index; LVEDVi ¼ left ventricular end-diastolic volume index;
LVEF ¼ left ventricular ejection fraction; LVESVi ¼ left ventricular end-systolic
volume index; NT-proBNP ¼ N-terminal pro–B-type natriuretic peptide.
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data analysis is provided in the Online Appendix.
VALIDATION OF T1 MEASUREMENTS. Imaging se-
quence and data analysis of T1 measurements were
validated by a relaxometry study as recommended byFIGURE 1 Example of Typical CMR Findings
Cardiac magnetic resonance (CMR) ﬁndings in a 42-year-old myocarditis
Short-axis T2-weighted short-tau inversion recovery (STIR) and late gad
myocardial edema and necrosis in the lateral wall, respectively. The T2
myocardial T2 was 62 ms in this patient. T1 mapping demonstrates regio
late post-contrast T1 on the post-contrast T1 map in this area. Mean glob
ms in this patient, respectively. Furthermore, the extracellular volume (
myocardial ECV was 35% in this patient.a recent consensus statement on T1 mapping (21).
Interscan repeatability was assessed for native T1
measurements by performing 10 repeated scans with
identical imaging parameters. Interobserver and
intraobserver reproducibility of data analysis was
assessed between 2 blinded observers and between
2 measurements, respectively. More detailed infor-
mation on the validation of T1 measurements is pro-
vided in the Online Appendix.
STATISTICAL ANALYSIS. Statistical analysis was
performed using GraphPad Prism version 5.00 for
Windows (GraphPad Software, San Diego, California)
and MedCalc for Windows, version 12.7.7.0 (MedCalc
Software, Ostend, Belgium). Continuous data are
presented as median and IQR. Categorical data are
presented as numbers and percentage. Bland-Altman
analysis was used to assess variability of measure-
ments. Continuous data were compared using the
nonparametric Mann-Whitney test. Categorical data
were analyzed using the Fisher exact test. A receiver-
operating characteristic (ROC) analysis was per-
formed to calculate optimal thresholds and areas
under the curves (AUCs). The Youden index was
used to depict optimal cutoff values from the ROC
curves, and AUCs were compared by the DeLong
method. Sensitivities, speciﬁcities, accuracies, andpatient who presented with acute chest pain and elevated troponin T.
olinium enhancement (LGE) showed an area with subepicardial
map showed increased T2 values in this area; the mean global
nally increased native T1 values on the native T1 map and decreased
al native and post-contrast myocardial T1 values were 1,076 and 394
ECV) demonstrated ECV expansion in this area, and the mean global
TABLE 2 CMR Characteristics in Myocarditis and Control Subjects
Myocarditis
(n ¼ 104)
Control Subjects
(n ¼ 21) p Value
T2w ratio 2.5 (2.2–2.9) 2.3 (2.1–3.0) 0.2706
EGE, % 61 (46–80) 49 (33–59) 0.0065
LGE 63 (61) 0 (0) <0.0001
T2, ms 61 (58–65) 55 (54–60) 0.0003
Native T1, ms 1,098 (1,057–1,139) 1,051 (1,010–1,063) <0.0001
Post-contrast T1, ms 555 (501–602) 579 (544–608) 0.1748
ECV, % 31 (28–34) 25 (24–27) <0.0001
Values are median (interquartile range) or n (%).
CMR ¼ cardiac magnetic resonance; ECV ¼ extracellular volume fraction; EGE ¼ early gado-
linium enhancement; LGE ¼ late gadolinium enhancement; T2w ratio ¼ signal intensity ratio of
myocardium to skeletal muscle on T2-weighted cardiac magnetic resonance.
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670positive and negative predictive values were calcu-
lated with 95% conﬁdence intervals using the
modiﬁed Wald method. Accuracies were compared
using McNemar tests. Statistical signiﬁcance was
set to p < 0.05 and was adjusted to p < 0.0025 using
the Bonferroni method to correct for multiple com-
parisons as appropriate.
RESULTS
VALIDATION OF T1 MEASUREMENTS. In the phan-
tom study, there was a good agreement between T1
values of the MOLLI sequence and the reference scan,
with a mean relative difference of 2  7%. TheA
FIGURE 2 ROC Curves for CMR Parameters to Identify Patients With
Receiver-operating characteristic (ROC) curves illustrate the diagnostic p
discriminate patients with myocarditis from control subjects. LGE provid
(p< 0.0001) of the Lake-Louise parameters. The ROC curve of LGE is rep
100% speciﬁcity of LGE (A). Myocardial ECV offered the best AUC, with
gadolinium enhancement; T2w ratio ¼ signal intensity ratio of myocardi
other abbreviations as in Figure 1.interscan variability was low, with an SD of 0.8% for
repeated native myocardial T1 measurements. Bland-
Altman analyses revealed good interobserver agree-
ments, with mean relative interobserver differences
of 1  2% for global pre-contrast T1, 0  4% for global
post-contrast T1, and 3  5% for global ECV. Mean
relative intraobserver differences were 0  2% for
global pre-contrast T1, 0  2% for global post-contrast
T1, and 1  6% for global ECV.
LAKE-LOUISE PARAMETERS. Nonischemic LGE was
found in 63 (61%) of the patients with myocarditis but
in none of the controls (Table 2). The AUCs were 0.80
(p < 0.0001) for the number of myocardial segments
with LGE, 0.58 (p ¼ 0.2692) for the T2w ratio, and 0.70
(p ¼ 0.0065) for EGE (Fig. 2A). The comparison matrix
for differences in AUC between single-tested CMR
parameters is provided in Table 3. The AUC of LGE
was signiﬁcantly larger compared with the AUC of the
T2w ratio (p ¼ 0.0049). Figure 3 and Table 4 demon-
strate the diagnostic accuracies of single Lake-Louise
criteria to discriminate patients with myocarditis
from control subjects. The presence of LGE provided a
speciﬁcity of 100% to identify patients with myocar-
ditis (Table 4). However, there were no signiﬁcant
differences in overall diagnostic accuracies between
LGE (67%), T2w ratio (70%), and EGE (70%), as
demonstrated by Tables 4 and 5.
T2, T1, AND ECV QUANTIFICATION. Global myocar-
dial T2, T1, and ECV were signiﬁcantly higher inB
Myocarditis
erformance of (A) “Lake-Louise” and (B) mapping parameters to
ed the best performance, with an area under the curve (AUC) of 0.80
resented by the dashed line overlaying the axis of ordinates due to the
0.86 (p < 0.0001) of the mapping parameters (B). EGE ¼ early
um to skeletal muscle on T2-weighted cardiac magnetic resonance;
TABLE 3 Comparison Matrix Between Areas Under the ROC Curves
ECV Native T1 PC T1 T2 T2w-Ratio EGE LGE
ECV —
Native T1 p ¼ 0.1282 —
PC T1 p ¼ 0.0041 p ¼ 0.0488 —
T2 p ¼ 0.1355 p ¼ 0.9165 p ¼ 0.0549 —
T2w ratio p ¼ 0.0025 p ¼ 0.0456 p ¼ 0.5381 p ¼ 0.0587 —
EGE p ¼ 0.0283 p ¼ 0.3887 p ¼ 0.3023 p ¼ 0.4445 p ¼ 0.1891 —
LGE p ¼ 0.4339 p ¼ 0.4330 p ¼ 0.0042 p ¼ 0.4989 p ¼ 0.0049 p ¼ 0.1547 —
PC T1 ¼ post-contrast global myocardial T1; ROC ¼ receiver-operating characteristic; other abbreviations as in Tables 1 and 2.
FIGURE 3 Diagnostic Accuracies of Single and Combined CMR Parameters
Accuracies are demonstrated for single conventional Lake-Louise and
mapping parameters. The stepwise use of LGE and ECV signiﬁcantly improved
the accuracy compared to any 2 of 3 Lake-Louise criteria (LL) (90% vs. 79%;
p ¼ 0.0043). Bars represent overall diagnostic accuracies; error bars indicate
95% conﬁdence intervals. LGE/ECV ¼ late gadolinium enhancement present
or extracellular volume $27%; PC T1 ¼ post-contrast global myocardial T1;
other abbreviations as in Figures 1 and 2.
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671patients with myocarditis compared with controls
(Table 2). The AUC were 0.86 (p < 0.0001) for
myocardial ECV, 0.78 (p ¼ 0.0003) for myocardial T2
(p ¼ 0.0310), 0.79 (p < 0.0001) for native myocardial
T1 (p ¼ 0.1282), and 0.59 (p ¼ 0.1738) for post-
contrast myocardial T1 (p ¼ 0.0041) (Fig. 2B). The
comparison matrix for differences in AUC between
single-tested CMR parameters is provided in Table 3.
The AUC of myocardial ECV was signiﬁcantly larger
compared with the T2w ratio, EGE, and post-contrast
myocardial T1 (Table 3). Myocardial ECV also had the
best diagnostic accuracy among single parameters:
76%, which was superior to myocardial T2 (p ¼
0.0310) and post-contrast myocardial T1 (p ¼ 0.0001)
(Fig. 3, Tables 4 and 5). The diagnostic performance
of single CMR parameters was also tested in the 62
(50%) subjects without LGE. In this subgroup, ROC
analyses revealed that ECV measurements provided
the best AUC: 0.86 (p < 0.0001), compared with 0.77
(p ¼ 0.0035) for myocardial T2 and 0.81 (p < 0.0001)
for native myocardial T1. The best diagnostic accu-
racy of 81% was found for a myocardial ECV $27%
cutoff in LGE negative patients.
COMBINED CMR PARAMETERS. The Lake-Louise
approach with any 2 of 3 fulﬁlled conventional
criteria provided a diagnostic accuracy of 79% to
discriminate between patients with myocarditis and
control subjects in our study population (Fig. 3,
Table 3). The accuracy of the Lake-Louise approach
was superior to LGE (p ¼ 0.0148), EGE (p ¼ 0.0003),
myocardial T2 (p ¼ 0.0049), and post-contrast
myocardial T1 (p ¼ 0.0001) (Table 5). A similar diag-
nostic accuracy was found for the Lake-Louise
approach compared with global myocardial ECV
(79% vs. 76%; p ¼ 0.6265) (Fig. 3, Table 3). A stepwise
use of LGE and ECV further improved diagnostic
accuracy: ﬁrst, patients were deﬁned as having
myocarditis by the presence of nonischemic LGE; and
second, myocarditis was assumed if global myocar-
dial ECV was $27% in LGE-negative patients (Fig. 4).The diagnostic accuracy of this approach (90%) was
superior to any single CMR parameter but also to the
Lake-Louise approach (p ¼ 0.0043) (Fig. 3, Table 5).
DISCUSSION
This study evaluated the diagnostic accuracy of T2,
T1, and ECV quantiﬁcation in comparison with cur-
rent Lake-Louise criteria for myocarditis. The major
ﬁndings were: 1) there was a perfect speciﬁcity, but
modest sensitivity for presence of LGE to identify
patients with myocarditis; 2) ECV quantiﬁcation
provided the best diagnostic accuracy of all single
CMR parameters to discriminate patients with myo-
carditis from control subjects; and 3) a stepwise use
of LGE and global myocardial ECV signiﬁcantly
TABLE 4 Diagnostic Accuracies of CMR Parameters
Sensitivity Speciﬁcity Accuracy NPV PPV
Lake-Louise parameters
T2w ratio ($2.2) 76 (67–85) 42 (22–63) 70 (61–77) 30 (16–49) 84 (75–91)
EGE ($56%) 63 (53–73) 71 (48–89) 59 (56–73) 31 (18–45) 91 (81–97)
LGE () 61 (51–70) 100 (84–100) 67 (59–75) 34 (22–47) 100 (94–100)
T2 and T1 mapping parameters
T2 ($61 ms) 57 (44–68) 89 (65–99) 63 (53–73) 35 (21–50) 95 (83–99)
Native T1 ($1,074 ms) 64 (54–74) 90 (70–98) 69 (60–76) 34 (22–48) 97 (90–100)
PC T1 (<534 ms) 40 (30–50) 82 (60–95) 47 (39–56) 23 (14–33) 91 (79–98)
ECV ($29%) 73 (63–81) 90 (70–98) 76 (68–83) 40 (26–56) 97 (91–100)
Combinations
Lake-Louise 84 (75–90) 57 (34–78) 79 (71–85) 41 (24–61) 90 (83–96)
LGEþ or ECV[ 94 (88–98) 71 (48–89) 90 (84–95) 71 (48–89) 94 (88–98)
Values are % (95% conﬁdence interval). Cutoff values are listed in parentheses after each parameter.
ECV[ ¼ extracellular volume fraction $27% in late gadolinium enhancement negative patients; NPV ¼ negative predictive value; PPV ¼ positive predictive value;
other abbreviations as in Tables 2 and 3.
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672improved the diagnostic accuracy of CMR in com-
parison with conventional Lake-Louise criteria.
LAKE-LOUISE CRITERIA. We found a similar diag-
nostic accuracy for any 2 of 3 Lake-Louise criteria:
79%, compared with 78% in the pooled data analysis
by Friedrich et al. (3) and 79% in a subset of biopsy-
proven acute myocarditis in a study by Lurz et al.
(22). In our study, LGE provided the best diagnostic
performance of single Lake-Louise parameters and
had a perfect speciﬁcity to identify patients with
myocarditis (Fig. 2A, Table 3). However, the diag-
nostic accuracy of LGE was limited due to a modest
sensitivity of 61% in agreement with the analysis by
Friedrich et al. (3), who found a sensitivity of 59%
for LGE by pooling 5 datasets. The consistently
modest sensitivity of LGE supports the notion that
current signal intensity-based Lake-Louise parame-
ters are limited in detecting diffuse myocardial injury
due to the dependence on reference myocardium or
skeletal muscle (3,22). Thus, there is a particular need
for a good discriminator between myocarditis and
healthy individuals in LGE-negative subjects with
possible diffuse myocardial injury.
T2 QUANTIFICATION. There were signiﬁcantly
increased global myocardial T2 values in patients
with myocarditis (Table 2), in agreement with
recent data by Thavendiranathan et al. (6), who
found focally-increased myocardial T2 values in pa-
tients with myocarditis. However, we did not ﬁnd
signiﬁcant differences between patients with myo-
carditis and control subjects for the signal intensity
ratio of myocardium to skeletal muscle by T2w
CMR. Therefore, T2 mapping CMR could be more
sensitive for detecting myocardial inﬂammation inmyocarditis compared with T2w CMR. Nevertheless,
the diagnostic accuracy of T2 quantiﬁcation was
modest and not superior to single Lake-Louise pa-
rameters in our study (Table 3, Fig. 3). This ﬁnding is
possibly related to the composition of the study
population, with a high incidence of patients with
recent-onset heart failure (66%) and a more subacute
clinical presentation 2 weeks (IQR: 1 to 7 weeks) after
onset of symptoms. Our ﬁndings support the recent
ﬁndings by Lurz et al. (22) and Monney et al. (23),
who reported an unsatisfactory diagnostic perfor-
mance of current CMR parameters in patients with a
more chronic clinical presentation. Patients with
subacute myocarditis may display various degrees of
myocardial necrosis/ﬁbrosis but less myocardial
edema and, therefore, can be missed by edema-
sensitive T2w CMR but also by T2 mapping CMR
(22,23).
T1 QUANTIFICATION. We found signiﬁcantly higher
native myocardial T1 values in patients with
myocarditis compared with control subjects (Table 2).
However, our absolute native T1 values were sys-
tematically higher compared with the native T1
values reported by Ferreira et al. (16). Median native
T1 values in our control group were 1,051 ms (IQR:
1,010 to 1,063 ms) compared with 941  18 ms in the
control group of Ferreira et al. (17). Furthermore, our
myocarditis patients had higher native T1 values:
median 1,098 ms (IQR: 1,057 to 1,139 ms) compared
with 1,010  65 ms in Ferreira et al. (17). In agreement
with current recommendations (21), we thoroughly
validated the MOLLI sequence as well as the T1 calcu-
lation method that was used in this study. We found
an excellent agreement for T1 quantiﬁcation between
TABLE 5 Comparison Matrix Between Diagnostic Accuracies
ECV Native T1 PC T1 T2 T2w Ratio EGE LGE LL LGE/ECV
ECV —
Native T1 p ¼ 0.1374 —
PC T1 p ¼ 0.0001 p ¼ 0.0012 —
T2 p ¼ 0.0310 p ¼ 0.2012 p ¼ 0.1547 —
T2w ratio p ¼ 0.6353 p ¼ 0.8802 p ¼ 0.0015 p ¼ 0.1360 —
EGE p ¼ 0.0910 p ¼ 0.3613 p ¼ 0.0070 p ¼ 0.4047 p ¼ 0.1183 —
LGE p ¼ 0.1447 p ¼ 0.8897 p ¼ 0.0011 p ¼ 0.1374 p ¼ 0.6885 p ¼ 0.5419 —
LL p ¼ 0.6265 p ¼ 0.0736 p ¼ 0.0001 p ¼ 0.0049 p ¼ 0.0543 p ¼ 0.0003 p ¼ 0.0148 —
LGE/ECV p ¼ 0.0003 p ¼ 0.0001 p ¼ 0.0001 p ¼ 0.0001 p ¼ 0.0001 p ¼ 0.0001 p ¼ 0.0001 p ¼ 0.0043 —
LGE/ECV ¼ late gadolinium enhancement present or extracellular volume $27%; LL ¼ any 2 of 3 Lake-Louise criteria; other abbreviations as in Tables 1 to 3.
FIGURE 4 Proposed Diagnostic Algorithm to Identify
Patients With Myocarditis Based on LGE and ECV Imaging
Myocarditis was deﬁned stepwise by the presence of LGE or by
an ECV $27% in LGE-negative patients. Abbreviations as in
Figure 1.
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673a reference scan and the MOLLI sequence in the
phantom experiment. Thus, the discrepancy between
the studies supports recent concerns that absolute
T1 values vary with the employed CMR sequence
(e.g., shortened MOLLI vs. MOLLI) and the algorithm
of T1 calculation (21,24). Therefore, measuring abso-
lute myocardial T1 values is currently of limited
diagnostic value in clinical routine due to a lack of
established normal values and thresholds (25).
The diagnostic accuracy of native T1 was lower in
our study: 69% compared with 90% in Ferreira et al.
(6,16). This discrepancy can be explained by a more
subacute clinical presentation of patients in our study
population, who underwent CMR at a median of 2
weeks (IQR: 1 to 7 weeks) after onset of symptoms. In
contrast, Ferreira et al. (16) exclusively included pa-
tients in the acute stage within 14 days after onset of
symptoms. CMR generally seems to provide a better
diagnostic accuracy in the acute phase of myocarditis
within 14 days after onset of chest pain (22,23). Thus,
the diagnostic accuracy of native T1, but also T2,
could have been better in populations with more
acute patients compared with our study population.
Despite performing post-contrast T1 mapping in a
standardized fashion at 15 min after contrast media
injection, we did not ﬁnd signiﬁcant differences in
post-contrast myocardial T1 values between patients
with myocarditis and control subjects. Interestingly,
post-contrast T1 had the lowest diagnostic accuracy
of all single parameters: 47% (Table 3, Fig. 3). Our
ﬁndings clearly demonstrate the limitations of
assessing absolute post-contrast T1 values, which are
prone to confounders such as differences in contrast
media formulation, relaxivity, imaging delay after
administration, and renal elimination (4,26,27).
ECV QUANTIFICATION. Expansion of myocardial
ECV can be observed in edema/inﬂammation as well
as in necrosis/ﬁbrosis (8,10–15,28). A major advantageof ECV imaging compared with standard CMR tech-
niques is the ability to assess diffuse myocardial
injury independent from reference tissue (4,26,29).
A major advantage in comparison with absolute T1
values is that ECV calculation compensates not only
for site-speciﬁc factors such as the T1 mapping
sequence or the algorithm of T1 calculation, but also
for confounding variables such as imaging delay after
contrast media injection (4,8,14,26). Our data de-
monstrate that ECV signiﬁcantly improved the diag-
nostic accuracy of CMR in myocarditis. Global
myocardial ECV had the best diagnostic accuracy of
any single CMR parameter (Fig. 3, Tables 4 and 5).
Interestingly, solely assessing global myocardial ECV
provided a similar diagnostic accuracy compared with
the Lake-Louise criteria (76% vs. 79%; p ¼ 0.6265).
Thus, ECV imaging could potentially simplify CMR
protocols in myocarditis by replacing current combi-
nations of several different parameters.
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PARAMETERS. The good accuracy for the Lake-
Louise criteria is in close agreement with the
pooled data analysis of Friedrich et al. (3), who found
an accuracy of 78%. We stepwise combined the per-
fect speciﬁcity of LGE with the excellent perfor-
mance of global myocardial ECV in patients without
LGE (Fig. 4). Myocarditis was identiﬁed by the pres-
ence of LGE or an increased global myocardial
ECV $27% in LGE-negative patients. This algorithm
resulted in a superior accuracy of 90% compared
with 79% for standard Lake-Louise criteria (p ¼
0.0043), but also compared to any single parameter
(Table 5). Our approach obviously detected more
patients with diffuse myocardial injury who were
missed by standard criteria.
STUDY LIMITATIONS. Our study population un-
derwent CMR in a subacute stage at a median of 2
weeks after onset of symptoms, and included a
relatively high proportion of patients with heart
failure (63%) with severe myocardial injury as indi-
cated by dynamic elevation of cardiac biomarkers
and the presence of LGE in 61% of patients. Thus,
our study population mainly represents more sub-
acute and more severe stages of myocarditis
compared with many recent studies (3,16,22,23). Our
control group had similar basic demographic char-
acteristics compared with myocarditis patients and
with recently-published controls for patients with
myocarditis (16). However, healthy control subjects
inherently introduce a potential bias and may not
be fully representative of symptomatic, but
myocarditis-negative individuals referred for diag-
nostic testing. Furthermore, our number of patients
and control subjects was similar to the ratio of
myocarditis positive to negative patients that is
typically found in our center. Testing the same
CMR parameters in other study populations with
more acute stages or a different severity or preva-
lence of myocarditis could result in varying diag-
nostic accuracies. The conclusions from this work
are, therefore, conﬁned to subacute, severe stages ofmyocarditis and settings with a high prevalence of
myocarditis.
An additional limitation of this study is the lack
of a systematic endomyocardial biopsy to detect
myocarditis. However, our ﬁndings on the accuracy
of Lake-Louise criteria with clinical validation agree
well with previous data using an endomyocardial
biopsy reference (22). Furthermore, we carefully
deﬁned the presence of myocarditis by combining
typical clinical features, exclusion of coronary ar-
tery disease, and elevated biomarkers similar to
recent studies with a clinical reference standard
(3,16,18,19).
The use of gadobenate dimeglumine may consti-
tute a concern because the majority of recent studies
on ECV imaging used diethylene triamine penta-
acetic acid (DTPA) contrast media (8,10–15,21). How-
ever, ECV values in our control group agree well with
recent large, population-based reference values (28).
Furthermore, we corrected for the higher relaxivity
of gadobenate dimeglumine by adjusting doses to
0.075 mmol/kg, and Kawel et al. (30) recently
demonstrated similar ECV values for the use of
gadobenate dimeglumine and DTPA (30). Addition-
ally, using the phased-array surface coil as receiver
for semiquantitative signal intensity analysis on T2w
and T1w CMR constitutes a discrepancy with recent
recommendations (3). However, we used an inherent
signal intensity correction algorithm to overcome
this potential limitation.
CONCLUSIONS
In patients with clinical evidence for subacute, severe
myocarditis, ECV quantiﬁcation with LGE imaging
signiﬁcantly improved the diagnostic accuracy of
CMR compared with standard Lake-Louise criteria.
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